FDAnews
www.fdanews.com/articles/101216-biotech-capital-to-invest-in-generic-health

Biotech Capital to Invest in Generic Health

November 19, 2007

Biotech Capital Limited will invest in Australia’s Generic Health, a supplier of pharmaceutical products whose patents are about to expire.

Generic Health’s portfolio of products accounts for 40 percent of generic sales in the Australian market. The size of the generics market is expected to grow by approximately 15 percent annually over the next four years, Biotech Capital said.

Generic Health has plans to launch generic versions of products whose patents expire between 2009 and 2013.